Ateneo School of Medicine and Public Health Year Level 8: Clerkship
Ateneo School of Medicine and Public Health Year Level 8: Clerkship
N/
A
History
Interval:
Duration:
Amount:
Symptoms:
Personal-Social History
Occupation: Manager
Smoking: 2 pack years
Alcohol: Occasional alcoholic beverage drinker
Drugs/ Other Vices: Denies
Review of Systems
BP:139/95
Temp:36.8
General Appearance: The patient is in Cardio-respiratory distress. He is alert and oriented to person,
place and time. In pain.
Chest/ Lungs: Symmetrical chest expansion, normal resonant percussion, clear breath sounds.
Cardiovascular: Adynamic precordium, no lifts or heaves, PMI in the 5th ICS MCL, S1>S2 at the apex,
S2>S1 at the base, no S3 or S4, no murmurs.
Abdomen: Flabby, no scars, normoactive bowel sounds, no tenderness on light and deep palpation, no
masses, no guarding.
Genitourinary: No CVA tenderness
Musculoskeletal: No cyanosis or clubbing, full ROM on all extremities, no swelling or tenderness on
muscles and joints
Skin: No lesions, good turgor
Initial Assessment:
ACS
Differential Diagnoses
1. GERD
2. Costochondritis
3. Anxiety attacks
4.CAP
5.
Complete Diagnosis on Discharge
2 V CAD
ST-elevation MI, anteroseptal wall
Impaired fasting glucose, pre-diabetes
Home Medications
1.Aspirin 50/tab
2.Clopidogrel 75mg/tab
3.Pantoprazole 40mg/tab
4.Atorvastatin 80mg/tab
5.Cardevilol 6.25mg/tab
6.Metformin 500 mg/tab
7.trimetadine 30mg/tab
Completed by:
_M.M__________________________
Clerk-In-Charge / Date / Time
Checked by:
Home Instructions
1 tab OD (12nn)
1 tab OD
1 tab OD
1 tab OD
1 tab BID hold for SBP <110, HR <11
1 tab OD hold if with diarrhea
1-tab BID
________________________________________________________
IM Resident-In-Charge / Date / Time
Drug Database
Generic Name:
Aspirin
Drug Class:
Anticoagulant, antiplatelets, fibrinolytics and
NSAID
Drug Structure:
Brand Names:
Aspilet
Dosage Forms:
Oral tablet
Drug Appearance:
Indications: Prophylactic treatment of thromboembolic disorders, MI, transient ischemic attacks (TIA) &
stroke. Secondary prevention of cerebrovascular events in patients w/ DM esp. those w/ history of MI, TIA
or minor stroke, angina & those w/ additional risk factors: HTN, smoking, dyslipidemia & family history of
CV disease; reinfarction in patients w/ previous MI; restenosis of CABG; thrombosis of arteriovenous shunts
in patients undergoing hemodialysis. Revascularization procedures. Pregnancy-induced HTN
Dosing: Suspected acute MI Initial dose: 160 mg. Maintenance dose: 160 mg/day continued for 30 days
post-MI. Prevention of recurrent MI, unstable angina pectoris & chronic stable angina pectoris, primary &
secondary prevention of CV events in patients w/ DM 75-325 mg once daily
Adverse Effects:
Fever, hypothermia, thirst. Dysrhythmias, hypotension, tachycardia. Agitation, cerebral edema, coma,
confusion, dizziness, headache, subdural or intracranial hemorrhage, lethargy, seizures. Dehydration,
hyperkalemia, metabolic acidosis, resp alkalosis, dyspepsia, GI bleeding, ulceration & perforation, nausea,
vomiting, transient hepatic enzyme elevations, hepatitis, Reye's syndrome, pancreatitis. Prolongation of
prothrombin time, disseminated intravascular coagulation, coagulopathy, thrombocytopenia. Acute
anaphylaxis, angioedema, asthma, bronchospasm, laryngeal edema, urticaria. Hearing loss, tinnitus.
Hyperpnea, pulmonary edema, tachypnea. Interstitial nephritis, papillary necrosis, proteinuria, renal
insufficiency & failure. Rhabdomyolysis. Hypo/hyperglycemia.
Metabolism/ Excretion
1% is excreted as unhydrolyzed in the urine
the remainder is excreted as salicylates and its
metabolites.
Bioavailability:
68%
Onset of Action
4-6 hours
Metabolites:
salicylic acid, its acyl and phenolic
glucuronides, salicyluric acid, its phenolic
glucuronide and gentisic acid.
Patient Correlation
Post MI patients are given aspirin to prevent stroke episodes especially so that the patient has
diabetes
Completed by:
M.M. ________________
Clerk-In-Charge / Date / Time
Checked by:
__________________________________________
______________
IM Resident-In-Charge / Date / Time
Problem
1/22/16
1.) Chest
heaviness
1/23/16
1.) Chest
heaviness
2.) Diarrhea
Acute ST-elevated
myocardial infarction
s/p stenting of Left
anterior descending
artery
Lactulose induced
diarrhea
Acute ST-elevated
myocardial infarction
s/p stenting of Left
anterior descending
artery
Lactulose induced
diarrhea
P
>Aspirin 80 mg/tab 4
tabs now, 1 tab OD after
>Atorvastatin 80mg/tab
1 OD
>Isordil 5mg SL now
>Pantoprazole 40mg IV
OD
>Enoxaparin 0.6ml SC
now then 2x a day
>Ticagradur 90mg/tab 2
tabs now then 1 tab 2x a
day
>Captopril 1 tab OD
>Tramadol and
paracetamol 1 tab TID
>Start Ranitidine
150mg/tab, 1-tab BID
>Clopidogrel 75mg/tab 1
tab OD
>Carvedilol 6.25mg 1
tab BID
>Hold Lactulose for now
>Observe for further
episodes of loose stools
>Stool charting
>IVF TF: PNSS
1LX60ml/hr
>Aspirin 80 mg/tab 1
tab OD
>Atorvastatin 80mg/tab
1 OD
>Pantoprazole 40mg IV
OD
>Enoxaparin 0.6ml SC
BID
>Ticagradur 90mg/tab 2
tabs now then 1 tab 2x a
day
>Shift Captopril to
Remipril 2.5mg/tab 1 tab
OD
>Tramadol and
paracetamol 1 tab TID
>Start Ranitidine
150mg/tab, 1 tab BID
>Clopidogrel 75mg/tab 1
tab OD
>Carvedilol 6.25mg 1tab BID
>Hold Lactulose
>Continue stool charting
>Continue IVF ratio at
60ml/hr
>Discontinue if IVF with
no loose bowel
movement
2.) Diarrhea
1/25/16
1.) Chest
heaviness
Acute ST-elevated
myocardial infarction
s/p stenting of Left
anterior descending
artery
Acute ST-elevated
myocardial infarction
s/p stenting of Left
anterior descending
artery
>Aspirin 80 mg/tab 1
tab OD
>Atorvastatin 80mg/tab
1 OD
>Pantoprazole 40mg IV
OD
>Enoxaparin 0.6ml SC
BID
>Ticagradur 90mg/tab 2
tabs now then 1 tab 2x a
day
>Hold Remipril
2.5mg/tab 1 tab OD
>Tramadol and
paracetamol 1 tab TID
>Start Ranitidine
150mg/tab, 1-tab BID
>Clopidogrel 75mg/tab 1
tab OD
>Carvedilol 6.25mg 1tab BID
>Hold Lactulose
>Start Meropenem
500mg/tab 1-tab BID
>Give metoclopramides
10mg/I now then every 8
hours as needed for
nausea/vomiting
>Give Kremil-S tablet, 1tab now
>Continue stool charting
>Continue IVF ratio at
60ml/hr
>Discontinue if IVF with
no loose bowel
movement
>Non-fatty, non-oily diet
>For fecalysis to rule out
C. dif
>Start Hidrasec tab 1
tab TID till stools are
formed
>Increase oral fluid
intake
>Aspirin 80 mg/tab 1
tab OD
>Atorvastatin 80mg/tab
1 OD
>Pantoprazole 40mg IV
OD
>Enoxaparin 0.6ml SC
BID
>Ticagradur 90mg/tab 2
2.) Acute
gastroenteritis
Acute gastroenteritis
resolving
1/26/16
MGH
Clerk: M.M
Rotation: IM
Area:
Reference: http://www.mims.com/
Checked
by:
Signature over name of faculty